These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21136021)

  • 1. Why an aspirin a day no longer keeps the doctor away ….
    Lordkipanidzé M
    Thromb Haemost; 2011 Feb; 105(2):209-10. PubMed ID: 21136021
    [No Abstract]   [Full Text] [Related]  

  • 2. 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease.
    Henry P; Vermillet A; Boval B; Guyetand C; Petroni T; Dillinger JG; Sideris G; Bal dit Sollier C; Drouet L
    Thromb Haemost; 2011 Feb; 105(2):336-44. PubMed ID: 21136023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients.
    Zisman E; Erport A; Kohanovsky E; Ballagulah M; Cassel A; Quitt M; Pizov R
    Eur J Anaesthesiol; 2010 Jul; 27(7):617-23. PubMed ID: 20035230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease.
    Grove EL; Hvas AM; Mortensen SB; Larsen SB; Kristensen SD
    J Thromb Haemost; 2011 Jan; 9(1):185-91. PubMed ID: 20955349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twice daily aspirin to improve biological aspirin efficacy in patients with essential thrombocythemia.
    Dillinger JG; Sideris G; Henry P; Bal dit Sollier C; Ronez E; Drouet L
    Thromb Res; 2012 Jan; 129(1):91-4. PubMed ID: 22014557
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.
    Neubauer H; Lask S; Engelhardt A; Mügge A
    Thromb Haemost; 2008 Feb; 99(2):357-62. PubMed ID: 18278186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aspirin resistance controversy: clinical entity or platelet heterogeneity?
    Freedman JE
    Circulation; 2006 Jun; 113(25):2865-7. PubMed ID: 16801473
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin resistance in patients with coronary artery disease - which test to use in routine management?
    Ghosh K; Shetty S; Mota L
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):324-6. PubMed ID: 18469557
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.
    Nielsen HL; Kristensen SD; Thygesen SS; Mortensen J; Pedersen SB; Grove EL; Hvas AM
    Thromb Res; 2008; 123(2):267-73. PubMed ID: 18499236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of platelet thromboxane A2 production ex vivo and in vivo by clopidogrel therapy.
    Armstrong PC; Dhanji AR; Tucker AT; Mitchell JA; Warner TD
    J Thromb Haemost; 2010 Mar; 8(3):613-5. PubMed ID: 19995405
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of platelet function with light transmission aggregometry in 24 patients supported with a continuous-flow left ventricular assist device: a single-center experience.
    Fiore M; James C; Mouton C; Calderon J; Barandon L; Ouattara A; Picard F
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):3119-25.e1. PubMed ID: 25212058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of aspirin response by Multiplate whole blood aggregometry and light transmission aggregometry.
    Pedersen SB; Grove EL; Nielsen HL; Mortensen J; Kristensen SD; Hvas AM
    Platelets; 2009 Sep; 20(6):415-20. PubMed ID: 19658002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
    Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
    J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of high on-treatment platelet reactivity in patients with ischemic heart disease: concordance between the Multiplate and VerifyNow assays.
    Consuegra-Sánchez L; López-Palop R; Cano P; Carrillo P; Picó F; Villegas M; Sanchis J; Kaski JC
    J Thromb Haemost; 2013 Feb; 11(2):379-81. PubMed ID: 23253198
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease.
    Pamukcu B; Oflaz H; Onur I; Oncul A; Umman B; Koylan N; Bugra Z; Meric M; Nisanci Y
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):461-5. PubMed ID: 17581321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel discontinuation and platelet reactivity following coronary stenting.
    Mylotte D; Peace AJ; Tedesco AT; Mangiacapra F; Dicker P; Kenny D; Foley DP
    J Thromb Haemost; 2011 Jan; 9(1):24-32. PubMed ID: 20961396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients.
    Postula M; Janicki PK; Rosiak M; Przybylkowski A; Kaplon-Cieslicka A; Grygorowicz T; Trzepla E; Filipiak KJ; Czlonkowski A; Opolski G
    Cardiol J; 2013; 20(2):170-7. PubMed ID: 23558875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.